PrometheusRoot
Blog Links Prometheans 100+ Why are you here?
← Prometheans 100+
×
Daphne Koller
legend
ResearcherFounderEducator
Wikipedia
courserastanfordgraphical-modelsinsitro

Related

legend Andrew Ng
← Prometheans 100+ Daphne Koller

Coursera co-founder, probabilistic graphical models pioneer

Daphne Koller

CEO & Founder — insitro

Profile

Daphne Koller is one of the foundational figures in modern machine learning — she spent two decades at Stanford helping make probabilistic graphical models a workable tool for real problems, and she co-wrote the textbook that taught everyone else how to do it. Before deep learning ate the world, PGMs were how you reasoned under uncertainty at scale, and Koller’s framing of Bayesian networks, Markov random fields, and structured inference shaped how a generation of researchers thought about machine learning. She was a MacArthur Fellow in 2004, is a member of the National Academy of Engineering and the National Academy of Sciences, and her work sits underneath a lot of the probabilistic intuitions that still show up in modern systems.

Developers mostly know her, though, for what she did next. In 2012 she and Andrew Ng turned Stanford’s experiment in free online CS courses into Coursera, and for a brief window it felt like universities might actually be disrupted. That didn’t quite happen, but Coursera did genuinely democratize access to AI education — if you learned ML from a MOOC in the 2010s, you probably learned it from a course she helped make possible. Her 2012 TED talk on online education is still the clearest articulation of what MOOCs were trying to be.

In 2018 she left Coursera to found insitro, a drug-discovery company betting that ML trained on massive, purpose-generated biological datasets can find drug targets humans can’t see. The thesis is important: insitro doesn’t just bolt models onto existing pharma pipelines — they generate their own data (induced pluripotent stem cells, high-content imaging, functional genomics) specifically so the models have something real to learn from. In January 2026 they acquired CombinAbleAI and launched TherML, a full-stack ML platform spanning small molecules, oligonucleotides, and antibodies, with their first drug candidate heading into clinical trials this year.

For anyone learning AI, Koller is worth studying for a specific reason: she’s the rare researcher who’s operated successfully in three completely different modes — deep theory, mass education, and applied industry — without losing rigor in any of them. The through-line is that she keeps choosing problems where ML could matter and then actually doing the work.

Books

Probabilistic Graphical Models: Principles and Techniques The definitive 1,200-page textbook on PGMs, co-authored with Nir Friedman — still the reference used in graduate ML courses at Stanford, CMU, and Johns Hopkins.

Key Articles & Papers

insitro: Rethinking drug discovery using machine learning 2018 — Koller's own manifesto for insitro — the clearest statement of why she thinks ML can change pharma, and what needs to be true for it to work. 'It will be a paradigm shift': Daphne Koller on machine learning in drug discovery 2020 — A substantive interview on why pharma's productivity problem is a data problem, and how insitro's data-generation strategy differs from typical AI-for-bio startups. insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design 2026 — The TherML platform launch — insitro's bet on being end-to-end across small molecules, oligonucleotides, and antibodies. Daphne Koller on Google Scholar — 122,000+ citations across 300+ papers in Science, Cell, Nature Genetics, NeurIPS, and ICML — a useful index for anyone digging into the PGM and computational biology work.

Spotify Podcasts

#475 – Demis Hassabis: Future of AI, Simulating Reality, Physics and Video Games
#475 – Demis Hassabis: Future of AI, Simulating Reality, Physics and Video Games
Daphne Koller | How machine learning could save millions of lives
Daphne Koller | How machine learning could save millions of lives
#93 – Daphne Koller: Biomedicine and Machine Learning
#93 – Daphne Koller: Biomedicine and Machine Learning
Is AI Drug Discovery Finally Here? - with Daphne Koller
Is AI Drug Discovery Finally Here? - with Daphne Koller
Daphne Koller on drug discovery and AI
Daphne Koller on drug discovery and AI
How AI can make drug discovery fail less, with Daphne Koller from Insitro
How AI can make drug discovery fail less, with Daphne Koller from Insitro
Recode Decode: Daphne Koller, president, Coursera
Recode Decode: Daphne Koller, president, Coursera
Daphnique Springs and Matt Braunger
Daphnique Springs and Matt Braunger
Meet The Leader at 200: 20 Leaders Share Their Best Tips, Aha Moments and Advice
Meet The Leader at 200: 20 Leaders Share Their Best Tips, Aha Moments and Advice
“Don’t Look Now” by Daphne du Maurier, Part 1 of 3
“Don’t Look Now” by Daphne du Maurier, Part 1 of 3

Related People

legend Andrew Ng
© 2026 PrometheusRoot